Vivek Vishnudas

Company: BPG Bio

Job title: Chief Technology Officer

Seminars:

Pioneering a Differentiated Approach to Targeted Protein Degradation Using the Ubiquitin Conjugating Enzyme (E2) Family 2:15 pm

Overcoming the challenge of modulating ubiquitin-conjugating enzymes with small molecules by identifying novel strategies to address the lack of druggable pockets Leveraging Fragment-Based Drug Design for PTM-E2 complexes to enable the discovery of first-in-class ligands that open new therapeutic avenues Developing efficacious bi-functional degraders through E2 ligand extension and molecular design to target multiple high-value…Read more

day: Day 1, Track 2, PM